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Available online 24 March 2016Objective. Inﬂammation is closely involved in the development of type 2 diabetes, and cigarette smoking acts
as potent inducer of inﬂammation. We therefore investigated interactions between inﬂammation-related gene
polymorphisms and cigarette smoking on glycated hemoglobin (HbA1c) in the Japanese general population.
Method. We conducted a cross-sectional study using data collected from 2619 Japanese (1274 males and
1345 females) 40–69 years of age who participated in baseline survey of the JapanMulti-Institutional Collabora-
tive Cohort (J-MICC) Study (2005–2008). Eight polymorphisms in seven genes (interleukin [IL]-1β, IL-2, IL-4, IL-8,
IL-10, IL-13 and tumor necrosis factor-α) were determined using the Invader assay. The interactions of smoking
and gene polymorphisms onHbA1c levelswere analyzed usingmultiple linear and logistic regressionmodels and
analysis of covariance with adjustment for potential confounders.
Results. Among the eight polymorphisms, only one signiﬁcant interaction was detected for IL-1β T-31C
(P b 0.0001). Among the subjects carrying TT genotype, current heavy smokers (≥20 cigarettes/day) had higher
HbA1c (5.83 [95% conﬁdence interval 5.67–5.99] %) versus all other smoking status groups (never 5.49
[5.41–5.56] %, former 5.54 [5.43–5.65] %, current moderate [b20 cigarettes/day] 5.50 [5.30–5.69] %), whereas
such differences were not observed in the subjects with C allele. The logistic regression analyses regarding
high-normal HbA1c levels showed a similar pattern of results.
Conclusion. Smoking status did not interact with any other inﬂammation-related polymorphisms except for
IL-1β T-31C. Heavy smokers harboring the TT genotype of IL-1β T-31C polymorphism show a greater adverse ef-
fect of smoking on HbA1c levels among Japanese middle-aged subjects.






Inﬂammatory cytokine. This is an open access article under1. Introduction
Inﬂammation plays a critical role in the pathogenesis of type 2
diabetes (Shoelson et al., 2006). The elevation of plasma inﬂammato-
ry cytokines (IL-1β and IL-6) precedes the development of type 2the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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temically, but also locally within insulin-sensitive tissues (e.g., liver
and skeletal muscle) and the pancreas. Inﬂammatory cytokines act
locally to interfere with insulin signaling at sites where they are pro-
duced, and local inﬂammation can induce β cell dysfunction and sub-
sequent insulin deﬁciency in the pancreatic islets of subjects with
type 2 diabetes mellitus (Shoelson et al., 2006; Esser et al., 2014).
Cigarette smoking is an environmental factor that potently induces
an inﬂammatory response. It is known that smokers have higher levels
of circulating inﬂammatory cytokines, such as IL-6, IL-8 and TNF-α, than
nonsmokers (Iho et al., 2003; Bermudez et al., 2002; Petrescu et al.,
2010). In an in vitro study, cigarette smoke condensate treatment in-
creased the expression levels of the IL-1β and IL-8 genes in normal
human bronchial epithelial cells, in which the degree of IL-1β gene in-
duction was greatest among the six cytokines examined (Hellermann
et al., 2002). The chemical species derived from smoking, such as
nicotine and cotinine, are detected in various biological samples
including saliva, hair, blood and urine (Matsumoto et al., 2013), thus in-
dicating that the toxic chemical species derived from cigarette smoke
are absorbed from the lung capillaries and spread throughout the
whole body to all organs, including insulin-sensitive tissues and the
pancreas.
Polymorphisms in inﬂammatory genes have been shown to be in-
volved in themodulation of the circulating inﬂammatory protein levels,
such as C-reactive protein and IL-6 (Pankow et al., 2001; Jerrard-Dunne
et al., 2004; Oberbach et al., 2008). Furthermore, it has been suggested
that the degree of inﬂammatory response to cigarette smoking may
differ according to individual's genotype for inﬂammatory genes
(Jerrard-Dunne et al., 2004). Although both external (i.e., cigarette
smoking) and internal (i.e., inﬂammatory-related gene polymor-
phisms) factors regulating inﬂammation have been shown to be associ-
ated with the development of type 2 diabetes and/or insulin resistance,
respectively (Kawakami et al., 1997; Nakanishi et al., 2000;
Wannamethee et al., 2001; Sairenchi et al., 2004; Willi et al., 2007;
Fernandez-Real et al., 2000; Kubaszek et al., 2003; Achyut et al., 2007;
Banerjee and Saxena, 2012), the interactions between inﬂammatory
polymorphisms and smoking on the glycemic control remain to be
elucidated. The glycated hemoglobin (HbA1c) level reﬂects the mean
plasma glucose level over the preceding 2–3 months (Rohlﬁng et al.,
2002), and this clinical index is commonly used to obtain a diagnosis
of diabetes.
The purpose of the current study was to investigate possible
gene–environment interactions between several inﬂammation-
related gene polymorphisms and cigarette smoking on the HbA1c
levels in the Japanese general population. We therefore conducted
the current cross-sectional study to test the hypothesis that the asso-
ciation of cigarette smoking on the HbA1c levels would be modiﬁed
by polymorphisms of genes that encode inﬂammatory cytokine
proteins.
2. Materials and methods
2.1. Subjects
In the current cross-sectional study, we analyzed data for 4512
Japanese subjects 40–69 years of age who voluntary participated in
the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study dur-
ing the period of 2005–2008. The study subjects were recruited from
10 different areas throughout Japan. The J-MICC study was launched
in 2005 to conﬁrm and detect gene–environment interactions involved
in the development of lifestyle-related diseases in the Japanese general
population, and the details of this cohort are described in detail else-
where (Hamajima and J-MICC Study Group, 2007; Wakai et al., 2011).
The J-MICC study was conducted in accordance with the ethical guide-
lines for epidemiological research of the Ministry of Education, Culture,
Sports, Science and Technology and the Ministry of Health, Labour andWelfare of Japan. Written informed consent was obtained from all par-
ticipants, and the study protocol was approved by the Ethics Commit-
tees at the Nagoya University Graduate School of Medicine and other
institutions participating in the J-MICC study.
2.2. Questionnaire and measurements
Data on cigarette smoking, alcohol consumption, dietary habits,
physical activity, aswell as currentmedications and past disease history,
were collected using a self-administered questionnaire. As for the
smoking status, the subjects were ﬁrst asked about their smoking status
from the past to the present. Then, the current smokers were requested
to report their usual cigarette consumption (cigarettes/day). The
smoking status was categorized as never, former, current 1–19, or
≥20 cigarettes/day. In the present study, current smokers who smoked
b20 cigarettes/day were described as moderate smokers, while current
smokers who smoked ≥20 cigarettes/day were described as heavy
smokers. The total energy intake and ethanol consumption were calcu-
lated using data obtained via a validated short food frequency question-
naire (FFQ) (Tokudome et al., 2004; Tokudome et al., 2005; Imaeda
et al., 2007). Ethanol consumption was categorized as never, former,
current 0.1–22.9, 23.0–45.9 or ≥46 g/day. The amount of habitual
physical activity more than an intensity corresponding to 3 metabolic
equivalents (METs) was assessed as previously described (Hara et al.,
2012). A ﬁrst-degree family history of diabetes was categorized as pos-
itive, negative or unknown. Anthropometric measurements and blood
sampling were conducted as part of the health checkup or for research
purposes at the institutions participating in the J-MICC study
(Hamajima and J-MICC Study Group, 2007). Height and weight were
measured to the nearest 0.1 cm and 0.1 kg, respectively. Body mass
index (BMI) was determined by dividing body weight in kilograms by
the square of height in meters. The HbA1c level was measured using a
latex aggregation immunoassay (Japan Diabetes Society [JDS] value).
The HbA1c value was estimated as the National Glycohemoglobin Stan-
dardization Program (NGSP) equivalent value calculated according to
the following formula: HbA1c (NGSP [%]) = 1.02 × HbA1c (JDS
[%]) + 0.25% (Kashiwagi et al., 2012). A signiﬁcantly elevated HbA1c
(high-normal HbA1c) level may be a superior clinical index for
predicting the development of type 2 diabetes (American Diabetes As-
sociation, 2010). An HbA1c level of 5.7% was used as a cut-off value to
deﬁne a high-normal 5.7% (Heianza et al., 2011).
2.3. Genotyping
One hundred and seven single-nucleotide polymorphisms were ge-
notyped using an Invader assay (Third Wave Technologies, Madison,
WI, USA) (Ohnishi et al., 2001) at the Laboratory for Genotyping Devel-
opment, Center for Genomic Medicine, RIKEN, as previously described
(Wakai et al., 2011). Among 107 single-nucleotide polymorphisms, we
selected eight polymorphisms in seven inﬂammatory genes for the cur-
rent analyses (IL-1β: T-31C [rs1143627], IL-2: T-330G [rs2069762], IL-4:
T-33C [rs2070874], IL-8: T-251A [rs4073], IL-10: T-819C [rs1800871],
IL-13: C-1111T [rs1800925], TNF-α: T-1031C [rs1799964] and TNF-α:
C-857T [rs1799724]). The genotype distributions of these eight poly-
morphisms did not deviate from Hardy–Weinberg equilibrium
(P N 0.05) (Wakai et al., 2011). The IL-6 C-634G polymorphism
(rs1800796) was not selected because its genotype distribution
deviated from Hardy–Weinberg equilibrium (P b 0.05) (Wakai et al.,
2011).
2.4. Statistical analysis
In the current analysis, 1893 subjects were excluded due to follow-
ing reasons: missing data on gene polymorphisms (IL-1β: n = 2, IL-2:
n = 6, IL-4: n = 2, IL-8: n = 27, IL-10: n = 11, IL-13: n = 4, TNF-α
T-1031C: n = 1, and TNF-α C-857T: n = 2), cigarette smoking status
Table 1
Characteristics of study subjects by sex. The J-MICC Study 2005–2008.





Age (years) 57.3 ± 8.6 56.9 ± 8.4 0.30
Height (cm)b 166.8 ± 6.1 154.0 ± 5.5 b 0.01⁎
Weight (kg)b 66.1 ± 9.9 53.7 ± 7.6 b 0.01⁎
BMI (kg/m2)b 23.7 ± 3.0 22.6 ± 3.1 b 0.01⁎
Energy intake (kcal/day) 1949 ± 355 1561 ± 259 b 0.01⁎
Physical activity (MET h/day)c 13.4 ± 13.2 12.7 ± 11.5 0.17
Smoking, n (%)
Never 348 (27.3) 1202 (89.4) b 0.01⁎
Former 563 (44.2) 57 (4.2)
Current moderate 1–19 cigarettes/day 119 (9.3) 54 (4.0)
Heavy ≥20 cigarettes/day 244 (19.2) 32 (2.4)
Drinking, n (%)d
Never 267 (21.3) 856 (64.7) b 0.01⁎
Former 28 (2.2) 23 (1.7)
Current 0.1–22.9 g/day 450 (35.9) 389 (29.4)
23.0–45.9 g/day 262 (20.9) 37 (2.8)
46.0+ g/day 247 (19.7) 18 (1.4)
Family history of diabetes, n (%) 189 (14.8) 215 (16.0) 0.36
HbA1c (%) 5.54 ± 0.64 5.48 ± 0.49 b 0.01⁎
TC (mg/dL) 205 ± 32 219 ± 35 b 0.01⁎
HDL-C (mg/dL) 58 ± 16 68 ± 16 b 0.01⁎
Values are expressed as themeans± standard deviation for continuous variables or num-
ber (percentage) for categorical variables. BMI, body mass index; MET, metabolic equiva-
lent; HbA1c, glycated hemoglobin; TC, total cholesterol; HDL-C, high density lipoprotein
cholesterol.
a P values for sex differences are based on t tests for continuous variables and chi-square
tests for categorical variables.
b Based on 1273 males.
c Based on 1265 males and 1331 females.
d Based on 1254 males and 1323 females.
⁎ P b 0.05.
290 Y. Nishida et al. / Preventive Medicine Reports 3 (2016) 288–295(n = 5), HbA1c (n = 1763), taking type 2 diabetes medications (n =
193) or having a dietary energy intake extraordinarily greater than
4000 kcal/day (n= 2). Consequently, 2619 subjects in seven investiga-
tion areas remained for the current analysis. Among these 2619
participants, there were subjects with missing data regarding alco-
hol consumption (20 males and 22 females), physical activity (9
males and 14 females), height (1 male), weight (1 male) and BMI
(1 male).
The statistical analyses were performed using the SAS software pro-
gram (version 9.3 for Windows, SAS Institute, Cary, NC, USA). A P value
of b0.05 was considered to be statistically signiﬁcant. Sex differences in
baseline characteristics were examined using the t test for continuous
variables or chi-square test for categorical variables. Because of the
low frequency of current smokers among females, males and females
were analyzed together and sex was included as an adjusted factor in
the following multivariate analyses. Multiple linear and logistic re-
gression analyses were performed to calculate the regression coefﬁ-
cients (β) and evaluate the associations (P trend) between the
cigarette smoking status (as an independent variable) and either the
HbA1c level or a high-normal HbA1c value (≥5.7%) (as dependent vari-
ables) according to each genotype of the eight polymorphisms. Adjust-
ment was made for the following potential confounding factors: sex
(categorical), age (continuous), BMI (continuous), energy intake (con-
tinuous), physical activity (continuous), alcohol drinking (categorical),
ﬁrst-degree family history of diabetes mellitus (categorical) and
investigation site (categorical). The smoking status was coded as
follows: never (0), former (1), current moderate (2) or current heavy
(3), treated as a continuous variable. Then, to identify gene
polymorphism(s) that can modify the associations between cigarette
smoking and the HbA1c level, interactions with gene polymorphisms
were assessed by including an interaction term, indicated as “gene poly-
morphism (categorical)*smoking status (continuous).” The genotypes
of the each polymorphism were coded as 0 for homozygous genotype,
1 for heterozygous genotype or 2 for the opposite homozygous
genotype.
Given that our current purpose was to identify inﬂammatory
polymorphisms that can modify the association of cigarette
smoking with the HbA1c level, and the interaction analysis was sta-
tistically signiﬁcant only for the IL-1β T-31C polymorphism among
the eight polymorphisms (Table 2), the subsequent analyses fo-
cused on the IL-1β T-31C polymorphism. The signiﬁcance of univar-
iate correlations between either the IL-1β T-31C polymorphism or
smoking status and selected characteristics (e.g., age and BMI)
was assessed according to Spearman's rank correlation coefﬁcient.
In the correlation analysis, a family history of diabetes was orderly
coded as 0 (negative), 1 (unknown), or 2 (positive). To assess the
associations of the IL-1β T-31C polymorphism and smoking status
with the HbA1c level, the adjusted mean value of HbA1c and its
95% conﬁdence interval (CI) according to the IL-1β T-31C genotype
or smoking status group were computed as least square means
using the general linear model procedure with the LSMEANS state-
ment in SAS. In these analyses, adjustment was made for sex and
age (model 1), with additional adjustment for BMI, energy intake,
physical activity, alcohol drinking, ﬁrst-degree family history of di-
abetes mellitus, investigation site, smoking status (for the evalua-
tion of the inﬂuence of the IL-1β T-31C polymorphism on the
HbA1c level) or IL-1β T-31C polymorphism (for the evaluation of
the inﬂuence of the smoking status on the HbA1c level) (model 2).
Similarly, the odds ratios (ORs) and 95% CIs of the IL-1β T-31C poly-
morphism and smoking status for a high-normal HbA1c value
(≥5.7%) were estimated using logistic regression models adjusted
for confounding factors, as described above.
Furthermore, an analysis of covariance (ANCOVA)wasused to calcu-
late the adjustedmeanHbA1c value (and95% CI) and compare the levels
between the smoking status groups within each IL-1β T-31C genotype.
In order to conduct a similar analysis on the risk of a high-normalHbA1c level, the ORs for high-normal HbA1c and their 95% CIs were
also calculated using never smokers in each genotype as a reference
group.3. Results
3.1. Characteristics of the study subjects
The characteristics of the study participants are shown in Table 1.
Agewas similar betweenmales and females, while both BMI and energy
intake were statistically signiﬁcantly higher in males than females
(P b 0.01). Cigarette smoking and alcohol drinkingweremore prevalent
among males than females (P b 0.01). The percentages of participants
who had a ﬁrst-degree family history of diabetes were similar between
the sex groups,while theHbA1c levelswere signiﬁcantly higher inmales
than females (P b 0.01).3.2. Interaction of inﬂammatory gene polymorphisms and cigarette
smoking on the HbA1c level and a high-normal HbA1c value
Among the eight gene polymorphisms investigated, only one
statistically signiﬁcant interaction was found for the IL-1β T-31C
polymorphism (P interaction b 0.0001), in which the P value was sta-
tistically signiﬁcant even after using Bonferroni correction
(Bonferroni-corrected P b 0.0063) (Table 2). None of the interactions
between the other seven polymorphisms and cigarette smoking on
the HbA1c level were statistically signiﬁcant (IL-2: P = 0.66, IL-4:
P = 0.78, IL-8: P = 0.08, IL-10: P = 0.09, IL-13: P = 0.50, TNF-α T-
1031C: P = 0.74, and TNF-α C-857T: P = 0.74). A similar pattern of
results was obtained from the logistic regression analyses with
respect to the risk of a high-normal HbA1c value, although the P
value was marginal for the interaction between the IL-1β T-31C
Table 2
Associations of smoking with HbA1c or high-normal HbA1c by each genotype of inﬂammatory polymorphisms, and interactions between smoking and gene polymorphism on the HbA1c
levels. The J-MICC Study 2005–2008.
Polymorphism Genotype HbA1c High-normal HbA1c
βa SE P trend P interactionb βa SE P trend P interactionb
IL-1β T-31C
[rs1143627]
CC (n = 584) −0.0040 0.0254 0.88 b0.0001⁎ 0.01 0.13 0.96 0.06
CT (n = 1274) −0.0004 0.0166 0.98 −0.02 0.09 0.81
TT (n = 761) 0.0963 0.0292 0.001 0.24 0.10 0.02
IL-2T-330G
[rs2069762]
TT (n = 1166) 0.0191 0.0214 0.37 0.66 0.10 0.09 0.28 0.54
TG (n = 1172) 0.0363 0.0189 0.05 0.12 0.09 0.18
GG (n = 281) 0.0533 0.0306 0.08 −0.21 0.20 0.29
IL-4T-33C
[rs2070874]
TT (n = 1181) 0.0305 0.0197 0.12 0.78 0.02 0.09 0.84 0.96
TC (n = 1162) 0.0193 0.0206 0.35 0.11 0.09 0.24
CC (n = 276) 0.0450 0.0318 0.16 0.17 0.19 0.38
IL-8T-251A
[rs4073]
AA (n = 1205) 0.0456 0.0197 0.02 0.08 0.09 0.09 0.29 0.97
AT (n = 1150) 0.0124 0.0186 0.51 0.07 0.09 0.42
TT (n = 264) 0.0768 0.0484 0.11 0.10 0.19 0.61
IL-10T-819C
[rs1800871]
TT (n = 1149) 0.0301 0.0198 0.13 0.09 0.09 0.09 0.29 0.82
CT (n = 1165) 0.0419 0.0212 0.05 0.05 0.09 0.61
CC (n = 305) −0.0059 0.0287 0.84 0.11 0.18 0.53
IL-13 C-1111T
[rs1800925]
TT (n = 87) −0.0294 0.0525 0.58 0.50 −0.75 0.59 0.20 0.41
TC (n = 785) 0.0421 0.0240 0.08 0.12 0.11 0.29
CC (n = 1747) 0.0277 0.0163 0.09 0.06 0.07 0.41
TNF-α T-1031C
[rs1799964]
TT (n = 1857) 0.0318 0.0157 0.04 0.74 0.07 0.07 0.31 0.82
CT (n = 691) 0.0312 0.0262 0.23 0.04 0.11 0.74
CC (n = 71) −0.0103 0.0522 0.84 −0.06 0.45 0.89
TNF-α C-857T
[rs1799724]
CC (n = 1745) 0.0310 0.0158 0.05 0.74 0.07 0.07 0.30 0.67
CT (n = 784) 0.0348 0.0258 0.18 0.08 0.12 0.51
TT (n = 90) −0.0132 0.0775 0.87 0.26 0.42 0.54
HbA1c, glycated hemoglobin; IL, interleukin; TNF, tumor necrosis factor; SE, standard error.
a β indicates regression coefﬁcient of multiple regression between smoking (independent variable) and either HbA1c or high-normal HbA1c (dependent variables).
b Interaction with smoking status.
⁎ P b 0.05.
291Y. Nishida et al. / Preventive Medicine Reports 3 (2016) 288–295polymorphism and cigarette smoking on a high-normal HbA1c value
(P interaction = 0.056).
3.3. Associations of the IL-1β T-31C polymorphism and cigarette smoking
status with selected characteristics
Table 3 shows the univariate associations of the IL-1β T-31C poly-
morphism and smoking status with the six selected characteristics.
The T allele of the IL-1β T-31C polymorphismwas signiﬁcantly and pos-
itively correlated with BMI and alcohol drinking. The current smokers
had higher BMI values, higher energy intake and higher percentages
of current drinkers and subjects with a ﬁrst-degree family history of
diabetes.Table 3









BMI (kg/m2)c 23.1 23.1 23.4 0.05 b0.01⁎
Energy intake (kcal/day) 1737 1745 1766 0.03 0.08
Physical activity
(MET·hours/day)d
13.1 13.0 13.0 0.00 0.91
Current smokers (%) 15.9 17.1 18.1 0.04 0.06
Current drinkers (%)e 50.2 55.4 56.2 0.04 0.04⁎
First-degree family history
of diabetes (%)
14.9 15.9 15.1 0.02 0.28
Data values are expressed as the means. IL, interleukin; BMI, body mass index; MET, metabolic
a Spearman's rank correlation coefﬁcients between either IL-1β polymorphism or smoking s
b P values for the Spearman's rank correlations.
c Based on 2618 subjects.
d Based on 2596 subjects.
e Based on 2577 subjects.
⁎ P b 0.05.3.4. Associations between the IL-1β T-31C polymorphism and smoking
status on the HbA1c levels
Table 4 shows the adjusted mean of the HbA1c level and ORs for a
high-normal HbA1c value according to the IL-1β T-31C polymorphism
or smoking status. The IL-1β T-31C polymorphism was not signiﬁ-
cantly associated with the HbA1c levels, whereas the smoking status
was signiﬁcantly and positively associated with the HbA1c levels fol-
lowing adjustment for all confounding factors (model 2 for HbA1c).
The current heavy smokers had the highest OR for a high-normal
HbA1c value (1.30 [95% CI 0.90–1.89]) in comparison to never
smokers, although the difference between these ORs did not reach











22.9 23.7 22.6 23.8 0.10 b0.01⁎
1668 1889 1789 1871 0.28 b0.01⁎
13.1 12.3 13.3 13.9 −0.05 0.01⁎
–
41.1 76.2 70.2 70.6 0.39 b0.01⁎
15.2 14.0 16.8 18.8 0.04 0.03⁎
equivalent.
tatus and six selected characteristics.
Table 4
Adjusted means of BMI (kg/m2), HbA1c (%) or odds ratios for high-normal HbA1c (≥5.7%) according to the IL-1β (T–31C) genotypes or cigarette smoking status. The J-MICC Study 2005–
2008.
IL-1β (T–31C) Smoking status
CC CT TT βa P
trend






Adjusted means of BMI
Model 1b 23.1 (22.9–23.4) 23.1 (22.9–23.2) 22.3 (23.1–23.5) 0.120 0.15 23.2 (23.0–23.4) 23.2 (22.9–23.5) 22.4 (21.9–22.9) 23.4 (23.0–23.8) −0.019 0.79
Model 2c 23.1 (22.9–23.4) 23.1 (22.9–23.3) 23.3 (23.1–23.5) 0.080 0.34 23.2 (23.0–23.3) 23.3 (23.0–23.5) 22.5 (22.0–22.9) 23.4 (23.0–23.8) −0.011 0.87
Adjusted means of HbA1c
Model 1b 5.49 (5.45–5.54) 5.50 (5.47–5.53) 5.53 (5.49–5.57) 0.022 0.16 5.50 (5.47–5.54) 5.50 (5.45–5.55) 5.45 (5.37–5.54) 5.58 (5.51–5.65) 0.017 0.20
Model 2c 5.50 (5.45–5.54) 5.50 (5.47–5.53) 5.53 (5.49–5.57) 0.016 0.29 5.49 (5.46–5.53) 5.50 (5.45–5.55) 5.47 (5.39–5.56) 5.61 (5.54–5.68) 0.030 0.02⁎
Adjusted odds ratios for high-normal HbA1c
Model 1b 1.00 (reference) 0.95 (0.76–1.20) 1.01 (0.78–1.30) 0.007 0.91 1.00 (reference) 1.17 (0.90–1.54) 0.83 (0.54–1.25) 1.08 (0.77–1.53) −0.001 0.99
Model 2c 1.00 (reference) 0.95 (0.74–1.21) 0.98 (0.75–1.28) −0.009 0.90 1.00 (reference) 1.24 (0.92–1.65) 1.04 (0.66–1.63) 1.30 (0.90–1.89) 0.070 0.24
Values are expressed as the adjusted means or odds ratios (95% conﬁdence interval). BMI, body mass index; HbA1c, glycated hemoglobin; IL, interleukin.
a Regression coefﬁcients for the associations between either IL-1β (T–31C) polymorphism or cigarette smoking status and HbA1c levels.
b Model 1: adjusted for sex and age.
c Model 2: adjusted for Model 1 and further adjusted for BMI (for the association between either IL-1β polymorphism or smoking status and HbA1c levels), energy intake,
physical activity, alcohol drinking, family history of diabetesmellitus, investigation site, smoking status (for the association of IL-1β polymorphismwith HbA1c levels) and IL-1β polymor-
phism (for the association of smoking with HbA1c levels).
⁎ P b 0.05.
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As shown in Fig. 1A, the adjusted HbA1c levels in the subjects carry-
ing the C allele (CC or CT) were similar among the four different
smoking status groups (CC: never 5.52 [95% CI 5.46–5.57] %, former
5.42 [5.32–5.52] %, current moderate 5.41 [5.24–5.58] %, current heavy
5.53 [5.39–5.67] %; CT: never 5.49 [5.45–5.53] %, former 5.51
[5.45–5.57] %, current moderate 5.49 [5.39–5.60] %, and current heavy
5.49 [5.40–5.58] %). In contrast, among the individuals carrying the TT
genotype, the HbA1c levels were signiﬁcantly higher in heavy smokers
(5.83 [5.67–5.99] %) than in all other smoking status groups (never
5.49 [5.41–5.56] %, former 5.54 [5.43–5.65] % and current moderate
5.50 [5.30–5.69] %). A similar pattern of results was observed regarding
a high-normal HbA1c value (Fig. 1B). The high-normal HbA1c risk
(adjusted OR) was signiﬁcantly higher in the subjects carrying the TT
genotype (never 1.00 [reference], former 1.21 [0.71–2.08], currentmod-
erate 1.35 [0.63–2.87] and current heavy 2.16 [1.14–4.10]), whereas the
ORs were similar among the participants with the C allele (CC: never
1.00 [reference], former 0.85 [0.44–1.64], current moderate 0.39
[0.11–1.41] and current heavy 1.22 [0.57–2.64]; CT: never 1.00 [refer-
ence], former 1.46 [0.96–2.22], current moderate 1.18 [0.61–2.27] and
current heavy 0.88 [0.48–1.62]).
3.6. Separate analyses according to sex
Since the smoking rate in females was low in the current subjects,
additional subanalyses on the interaction between cigarette smoking
and IL-1β T-31C polymorphism on HbA1c values were performed for
males and females. While interactions between the IL-1β T-31C poly-
morphism and cigarette smoking on the HbA1c levels were not signiﬁ-
cant in females alone (HbA1c: P interaction = 0.80; high-normal
HbA1c: P interaction = 0.65), signiﬁcant interactions were observed
when analyzed in males alone (HbA1c: P interaction = 0.0016; high-
normal HbA1c: P interaction = 0.0796). As shown in Table 5, adjusted
HbA1c and high-normal HbA1c values in male subjects showed a similar
pattern to that for males and females combined.
4. Discussion
In the current study, we investigated whether the inﬂuence of
cigarette smoking on the HbA1c levels varied according topolymorphisms of inﬂammatory genes in a middle-aged Japanese pop-
ulation. Of the eight gene polymorphisms examined, only one statisti-
cally signiﬁcant interaction was detected for the IL-1β T-31C
polymorphism (P interaction b 0.0001). The association between ciga-
rette smoking and the HbA1c levels in subjects carrying C allele (CT or
CC genotype) did not reach statistical signiﬁcance, whereas the smoking
status was positively associated with higher levels of HbA1c in the indi-
viduals harboring the TT genotype (P trend = 0.001). A similar pattern
of results was observed regarding the risk of high-normal HbA1c. There-
fore, the current results suggest that heavy smokers with the TT geno-
type of the IL-1β T-31C polymorphism may show a greater adverse
effect of smoking on the HbA1c levels among middle-aged Japanese
subjects.
As mentioned in the introduction, the IL-1β gene expression re-
sponse to cigarette smoking condensate was highest compared with
several inﬂammation-related genes (Hellermann et al., 2002), therefore
we presumed that its high reactivity to smoking could be a reason for
the sole signiﬁcant interaction detected in the current study. IL-1β is a
major proinﬂammatory cytokine that is known to be produced fromen-
dothelial or epithelial cells and macrophages and plays a central role in
the regulation of inﬂammatory responses (Banerjee and Saxena, 2012).
IL-1β adversely affects peripheral insulin sensitivity; however, it is espe-
cially well known to be closely involved in the impairment of β-cells in
pancreatic islets (Banerjee and Saxena, 2012). There are clinical reports
showing that blocking the biological activity of IL-1β (via the adminis-
tration of IL-1-receptor antagonist or IL-1β-speciﬁc antibody) improves
both the HbA1c level and insulin secretion, but not peripheral insulin
sensitivity (Larsen et al., 2007; Donath and Shoelson, 2011;
Sloan-Lancaster et al., 2013).
IL-1βmRNA is primarily synthesized as an inactive precursor IL-1β
(called pro-IL-1β) and the immature protein is then digested by the
proteolytic enzyme caspase 1 to produce a biologically active mature
formof IL-1β (Dinarello, 2011). The IL-1β T-31C is a TATA-box polymor-
phism that profoundly affects DNA-protein interactions in vitro; the
-31T allele has been shown to have a 5-fold enhanced binding activity
with the transcription initiation factor by way of preserving TATA-box
(El-Omar et al., 2000). Similarly, another study showed that the -31T al-
lele is associated with a 10-fold increase in the transcriptional activity
compared with the -31C allele (Chakravorty et al., 2006). Therefore, al-
though the current subjects carrying the TT genotype might have had
higher IL-1β production and may be susceptible to high HbA1c levels,
as shown in Table 4, an increase in the T allele alone was not
Fig. 1. Inﬂuence of cigarette smoking on the HbA1c levels according to the IL-1β T-31C genotypes in themiddle-aged Japanese subjects. Plots represent adjustedmeans of HbA1c (A) or ORs
for high-normal HbA1c (B) and their 95% CIs. The J-MICC Study 2005–2008.
Table 5
Inﬂuence of cigarette smoking on the HbA1c levels according to the IL-1β T-31C genotypes in male subjects. The J-MICC Study 2005–2008.
IL-1β (T–31C) genotypes Smoking status βa P trend
Never Former Current
Moderate (b20 cigarettes/day) Heavy (≥20 cigarettes/day)
Adjusted means of HbA1c
CC (n = 263) 5.55 (5.43–5.66) 5.47 (5.38–5.56) 5.50 (5.29–5.72) 5.52 (5.38–5.66) −0.0053 0.86
CT (n = 612) 5.49 (5.42–5.56) 5.52 (5.46–5.57) 5.54 (5.42–5.66) 5.48 (5.40–5.57) 0.0001 1.00
TT (n = 399) 5.48 (5.31–5.65) 5.59 (5.45–5.72) 5.54 (5.23–5.85) 5.90 (5.69–6.10) 0.1279 b0.01⁎
Adjusted odds ratios for high-normal HbA1c
CC (n = 263) 1.00 (reference) 1.17 (0.53–2.58) 0.41 (0.08–2.22) 1.19 (0.45–3.18) 0.0068 0.97
CT (n = 612) 1.00 (reference) 1.53 (0.92–2.54) 1.80 (0.82–3.96) 0.95 (0.48–1.91) 0.0064 0.95
TT (n = 399) 1.00 (reference) 1.75 (0.94–3.28) 2.04 (0.79–5.32) 2.61 (1.23–5.55) 0.2982 0.013⁎
Values are expressed as the adjusted means or odds ratios (95% conﬁdence interval). HbA1c, glycated hemoglobin; IL, interleukin. Adjusted for sex, age, body mass index, energy intake,
physical activity, alcohol drinking, family history of diabetes mellitus and investigation site.
a Regression coefﬁcients for the associations between cigarette smoking status and HbA1c levels.
⁎ P b 0.05.
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support the concept that IL-1β plays an important role in controlling
the blood glucose level (Spranger et al., 2003; Achyut et al., 2007;
Banerjee and Saxena, 2012).
However, the current results showed that overlap of the IL-1β T-31C
TT genotype and heavy smoking (≥20 cigarettes/day) may be unfavor-
ably linked to higher HbA1c levels, as shown in Fig. 1 and Table 5.
There is a possible explanation for these results. It has been demonstrat-
ed in an animal study that cigarette smoke exposure increases the pro-
teolytic caspase 1 activity as well as release of mature (biologically
active) IL-1β (Eltom et al., 2011). Therefore, the current heavy smokers
carrying the TT genotype might have demonstrated enhanced proteo-
lytic cleavage of immature IL-1β by caspase 1, presumably activated
by their heavy smoking, in pancreatic islets, in addition to preserving
the increased synthesis of the IL-1β precursor due to the -31T genotype.
Hence, we speculate that the coincidence of these two undesirable
properties (i.e., the IL-1β T-31C TT genotype and heavy smoking) may
lead to impaired insulin secretion, which can worsen the HbA1c level.
The present result, namely that cigarette smoking was positively
associated with higher HbA1c levels only when adjusted for BMI (as
shown in model 2 for the HbA1c levels in Table 4), is consistent with a
previous report indicating that heavy smoking has a protective effect re-
garding the future development of type 2 diabetes, mainly through the
protection from obesity (Onat et al., 2007). It is well known that
smoking has innumerable harmful effects on overall health in addition
to a detrimental inﬂuence on the blood glucose level; smoking cessation
should be highly encouraged among all current smokers, regardless of
their distinct IL-1β T-31C genotype. However, achieving smoking cessa-
tion is quite cumbersome, assumingly because of the effects of nicotine
dependence or addiction and/or insufﬁcient motivation or drive to quit
smoking. The current research provides evidence that smoking is espe-
cially harmful to individuals bearing the IL-1β T-31C TT genotype from
the perspective of type 2 diabetes prevention, and this information
may help individuals with the IL-1β T-31C TT genotype to avoid starting
smoking or possibly consider smoking cessation. Therefore, the present
ﬁndings are expected to contribute to the development of individual-
ized smoking cessation programs based on a person's genetic
background.
The current study is associated with several limitations. First, since
we excluded participants currently using type 2 diabetes medications
(n=193) from the present analyses in order to avoid potential reversal
of cause and effect, wewere unable to assess the inﬂuence on the devel-
opment of type 2 diabetes. Second, we have no replication data accom-
panying this study. Conﬁrmation of the present ﬁndings by other
researchers is expected in the future. Third, although we speculated
that the higher levels of HbA1c noted in the current heavy smokers hav-
ing the IL-1β T-31C TT genotypemay be attributed to insulin deﬁciency,
we have no data on the circulating insulin concentrations. Additionally,
the expression levels of the IL-1β gene in pancreatic β cells were not in-
vestigated, as performing a needle biopsy of the pancreas is impractica-
ble in epidemiological studies. Finally, it should be noted that smoking
may beneﬁcially affect individuals harboring autoimmune activation
(Onat and Can, 2014; Altay et al., 2015; Rasouli et al., 2013), however,
we had pertinent no data to identify such individuals in the current
population.
5. Conclusion
We found an interaction between the IL-1β T-31C polymorphism
and the cigarette smoking status regarding the HbA1c levels, as heavy
smokers harboring the TT genotype of IL-1β T-31Cmay exhibit a greater
adverse effect of cigarette smoking on the HbA1c levels. The smoking
status did not interact with any other inﬂammation-related polymor-
phisms except IL-1β T-31C. Further studies are needed to conﬁrm the
current results in different subject populations and understand the
precise mechanisms underlying this interaction.Conﬂicts of interest statement
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